Bozena Kuran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bozena Kuran has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Grazyna Mlynarczyk
Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland
2 shared publications - Irena Wolska
Adam Mickiewicz University, Faculty of Chemistry, Department of Crystallography
2 shared publications Jerzy Kossakowski
2 shared publications- Jerzy Kossakowski
Department of Medical Chemistry, Medical University, 3 Oczki Str., 02-007 Warszawa, Poland
2 shared publications Mariola Krawiecka
2 shared publications- Mariola Krawiecka
Med Univ Warsaw, Chair & Dept Biochem, PL-02097 Warsaw, Poland
2 shared publications
Latest Publications
- 5 January 2013
- Vol. 69 (6) , 1055-65
Synthesis and characterization of selected methyl 5-methoxy-2-methyl-1-benzofuran-3-carboxylate derivatives with potential antimicrobial activity.
Halogen and aminoalkyl derivatives of methyl 5-methoxy-2-methyl-1-benzofuran-3-carboxylate were prepared using 5-hydroxy-2-methyl-3-benzofuranocarboxylic acid as starting material. (1)H-NMR spectra were obtained for all of the synthesized structures, and for compounds 1 and 2 X-ray crystal structures were obtained too. All derivatives were tested for antimicrobial activity against a selection of Gram-positive cocci, Gram-negative rods and yeasts.
- 5 January 2013
- Vol. 69 (6) , 1055-65
Synthesis and characterization of selected methyl 5-methoxy-2-methyl-1-benzofuran-3-carboxylate derivatives with potential antimicrobial activity.
Halogen and aminoalkyl derivatives of methyl 5-methoxy-2-methyl-1-benzofuran-3-carboxylate were prepared using 5-hydroxy-2-methyl-3-benzofuranocarboxylic acid as starting material. (1)H-NMR spectra were obtained for all of the synthesized structures, and for compounds 1 and 2 X-ray crystal structures were obtained too. All derivatives were tested for antimicrobial activity against a selection of Gram-positive cocci, Gram-negative rods and yeasts.
- 16 October 2012
- Vol. 69 (5) , 901-10
Synthesis and biological activity of a novel series of 17-azapentacyclo [6.6.5.0(2.7).0(9.14).0(15,19)]nonadeca-2,4,6,9,11,13-hexaen-16,18-dione derivatives.
In the search for novel antimicrobial agents, a series of new derivatives - N-substituted imides were prepared. All of the compounds were characterized by 'H NMR and ESI MS spectra. These derivatives were tested for antimicrobial activity. Microorganisms used in this study included aerobic and facultative anaerobic bacteria such as Staphylococcus aureus, Escherichia coli, Stenotrophomonas maltophilia, and obligatory anaerobes such as Bacteroides fragilis, Bacteroides thetaiotaomicron and Propionibacterium acnes. Moreover, Candida albicans yeast was used. For representatives of all species the MICs of the investigated compounds were determined. Most of investigated derivatives had no antimicrobial activity (MIC > 512 mg/L) except the derivative 22 which showed slight activity against Gram-positive aerobes and anaerobes.
- 16 October 2012
- Vol. 69 (5) , 901-10
Synthesis and biological activity of a novel series of 17-azapentacyclo [6.6.5.0(2.7).0(9.14).0(15,19)]nonadeca-2,4,6,9,11,13-hexaen-16,18-dione derivatives.
In the search for novel antimicrobial agents, a series of new derivatives - N-substituted imides were prepared. All of the compounds were characterized by 'H NMR and ESI MS spectra. These derivatives were tested for antimicrobial activity. Microorganisms used in this study included aerobic and facultative anaerobic bacteria such as Staphylococcus aureus, Escherichia coli, Stenotrophomonas maltophilia, and obligatory anaerobes such as Bacteroides fragilis, Bacteroides thetaiotaomicron and Propionibacterium acnes. Moreover, Candida albicans yeast was used. For representatives of all species the MICs of the investigated compounds were determined. Most of investigated derivatives had no antimicrobial activity (MIC > 512 mg/L) except the derivative 22 which showed slight activity against Gram-positive aerobes and anaerobes.
- 1 January 2012
- Vol. 69 (1) , 145-148
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NOVEL SERIES OF 6,7-DIMETHOXYQUINAZOLINE-2,4(1H,3H)-DIONE DERIVATIVES
- 1 January 2012
- Vol. 69 (1) , 145-148
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A NOVEL SERIES OF 6,7-DIMETHOXYQUINAZOLINE-2,4(1H,3H)-DIONE DERIVATIVES
- Open Access
Synthesis and Preliminary Evaluation of the Antimicrobial Activity of Selected 3-Benzofurancarboxylic Acid Derivatives
Halogen derivatives of selected 3-benzofurancarboxylic acids were prepared using 6-acetyl-5-hydroxy-2-methyl-3-benzofuranocarboxylic acid as starting material. 1H-NMR spectra were obtained for all of the synthesized structures, and for compound VI, an X-ray crystal structure was also obtained. All derivatives were tested for antimicrobial activity against a selection of Gram-positive cocci, Gram-negative rods and yeasts. Three compounds, III, IV, and VI, showed antimicrobial activity against Gram-positive bacteria (MIC 50 to 200 mg/mL). Compounds VI and III exhibited antifungal activity against the Candida strains C. albicans and C. parapsilosis (MIC – 100 mg/mL).
Open AccessSynthesis and Preliminary Evaluation of the Antimicrobial Activity of Selected 3-Benzofurancarboxylic Acid Derivatives
Halogen derivatives of selected 3-benzofurancarboxylic acids were prepared using 6-acetyl-5-hydroxy-2-methyl-3-benzofuranocarboxylic acid as starting material. 1H-NMR spectra were obtained for all of the synthesized structures, and for compound VI, an X-ray crystal structure was also obtained. All derivatives were tested for antimicrobial activity against a selection of Gram-positive cocci, Gram-negative rods and yeasts. Three compounds, III, IV, and VI, showed antimicrobial activity against Gram-positive bacteria (MIC 50 to 200 mg/mL). Compounds VI and III exhibited antifungal activity against the Candida strains C. albicans and C. parapsilosis (MIC – 100 mg/mL).
- 24 July 2008
- Vol. 65 (3) , 371-5
Synthesis of N-substituted derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and screening of cytotoxic activity of selected azatricycloundecane compounds.
This paper reports the synthesis of a number of aminoalkyl derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and 1,11 -dimethyl-4-azatricyclo [5.2.2.0(2,6)]undecan-3,5,8-tri-one. Fourteen compounds were prepared and the in vitro cytotoxic activities were evaluated against human cancer cell lines originating from solid tumors in the National Cancer Institute, Bethesda, MD, USA.
- 24 July 2008
- Vol. 65 (3) , 371-5
Synthesis of N-substituted derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and screening of cytotoxic activity of selected azatricycloundecane compounds.
This paper reports the synthesis of a number of aminoalkyl derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and 1,11 -dimethyl-4-azatricyclo [5.2.2.0(2,6)]undecan-3,5,8-tri-one. Fourteen compounds were prepared and the in vitro cytotoxic activities were evaluated against human cancer cell lines originating from solid tumors in the National Cancer Institute, Bethesda, MD, USA.
- 8 March 2008
- Vol. 64 (6) , 527-33
Synthesis and preliminary evaluation of aminoalkanol derivatives of selected azatricycloundecane system for binding with beta-adrenergic and 5HT1A and 5HT2A receptors.
A series of aminoalkanol derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)] undec-8-en-1-yl acetate and 1,11-dimethyl-4-azatricyclo[5.2.2.0(2,6)]undecane-3,5,8-trione was prepared. The pharmacological profile of selected compounds was evaluated for affinity to beta-adrenoreceptors and serotoninergic receptors (5HT1A and 5HT2A).
- 8 March 2008
- Vol. 64 (6) , 527-33
Synthesis and preliminary evaluation of aminoalkanol derivatives of selected azatricycloundecane system for binding with beta-adrenergic and 5HT1A and 5HT2A receptors.
A series of aminoalkanol derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)] undec-8-en-1-yl acetate and 1,11-dimethyl-4-azatricyclo[5.2.2.0(2,6)]undecane-3,5,8-trione was prepared. The pharmacological profile of selected compounds was evaluated for affinity to beta-adrenoreceptors and serotoninergic receptors (5HT1A and 5HT2A).